CA49982-2A - 0x0000000000006A52

Healthy Males & Females

Twilight

* Stipend may pay up to reflected amount.
Start Date: 
March 22, 2026 - 2:00pm
End Date: 
April 1, 2026 - 8:30am

Study Details

Study Number: CA49982
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00

Study Criteria

Age: 19 - 60
BMI: 19 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to treat excessive sleepiness in people who work overnights.
Route of Administration: Oral
Blood Draws: 21

Study Schedule

Schedule Type:
Study Length: 3 - Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Thursday 3/12/2026
Friday 3/13/2026
Wednesday 3/18/2026
Friday 3/20/2026
Saturday 3/21/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 3/12/2026
Friday 3/13/2026
Wednesday 3/18/2026
Friday 3/20/2026
Saturday 3/21/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 3/22/2026 2:00:00 PM Wednesday 3/25/2026 11:30:00 AM 1 Lincoln
Return Wednesday 4/1/2026 7:30:00 AM Wednesday 4/1/2026 8:30:00 AM 1 Lincoln